If you liked this article you might like

New Setback for Sanofi's Lantus Increases Need for M&A
Allergan's Dealmaking Continues With Vitae Takeout
How Will Regeneron (REGN) Stock React to Cholesterol Drug Trial Success?
Pfizer's Deal to Buy Medivation May Give the Company Its Groove Back